Patients presenting with chest pain and shortness of breath are time-critical emergencies that leave your lab no room for error or delay in completing cardiac diagnostic tests. Achieving the best patient outcomes requires the fastest intervention possible.
Exceptional assay performance to inform treatment decisions
Our ValuMetrix® services team has proven results: one STAT lab increased testing volume by 82.6% without adversely impacting turnaround time.
*China ValuCheck® report. Data on file.
Don't waste time waiting: with a 24-hour ready mode, Vitros® Systems are ready when you are, with no ramp-up time.
Learn how Vitros® Automation Solutions can drive faster turnaround time, improved safety and a reduction in staffing requirements.
Our assays are designed to consistently produce accurate results – the first time – so your lab can reduce errors, deliver quality results and help clinicians set the course for quality patient care.
Vitros® High-Sensitivity Troponin Assay*
Provides high analytical sensitivity and precision for the detection of small changes at the 99th percentile, enabling early diagnosis of acute myocardial infarction.
Vitros High-Sensitivity Troponin assay*
Features a high negative predictive value that helps reduce emergency department crowding and requires fewer tests to rule out
Meets all International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) requirements for classification as a high-sensitivity troponin assay
Shows excellent prognostic value as an aid in the assessment of cardiac-related mortality/MI and all-cause mortality over 30 days and 12 months
Is compliant for use with guidelines for management of acute coronary syndrome, including ESC, AHA and NICE
*Vitros High-Sensitivity Troponin Assay is not available in all countries. Please check with your local QuidelOrtho representative for availability.
Vitros® NT-proBNP II Assay
NT-proBNP II is more stable than BNP, an important feature when samples must be transported.1
Vitros NT-proBNP II assay:
Validated for use with ICON age-specific, cutoffs, which optimize diagnosis decisions, accounting for age and renal function with better specificity of acute dyspnea cases1-5
Long calibration interval at 70 days
Automated, on-the-fly loading of consumables and reagents with no interruptions
Intelligent sampling order to balance processing demands
Correlates well with most other NT-proBNP assays5
Optimize patient outcomes and combine laboratory testing with emergency room testing
1. Kim HN, Januzzi JL Jr. Natriuretic peptide testing in heart failure. Circulation. 2011;123(18):2015-2019. doi:10.1161/CIRCULATIONAHA.110.979500
2. Masson S, Latini R, Anand IS, et al. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: The Valsartan Heart Failure (Val-HeFT) data. Clin Chem. 2006; Aug;52(8):1528-1538. doi:10.1373/clinchem.2006.069575
3. Januzzi JL Jr, Camargo CA, Anwaruddin S, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol. 2005;95(8):948-954. doi:10.1016/j.amjcard.2004.12.032
4. Januzzi JL, van Kimmenade R, Lainchbury J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients. Eur Heart J. 2006;27(3):330-337. doi:10.1093/eurheartj/ehi631
5. Vardeny O, Miller R, Solomon SD. Combined neprilysin and renin-angiotensin system inhibition for the treatment of heart failure. JACC Heart Fail. 2014;2(6):663-670. doi:10.1016/j.jchf.2014.09.001
Apolipoprotein A1
Vitros® 7600 Integrated System
Vitros® 5600 Integrated System
Vitros® 4600 Chemistry System
Apolipoprotein B
Vitros® 7600 Integrated System
Vitros® 5600 Integrated System
Vitros® 4600 Chemistry System
Cholesterol
Vitros® 7600 Integrated System
Vitros® 5600 Integrated System
Vitros® 4600 Chemistry System
Vitros® XT 3400 Chemistry System
CK
Vitros® 7600 Integrated System
Vitros® 5600 Integrated System
Vitros® 4600 Chemistry System
Vitros® XT 3400 Chemistry System
CK-MB
Vitros® 7600 Integrated System
Vitros® 5600 Integrated System
Vitros® 3600 Immunodiagnostic System
Vitros® ECI/ECiQ Immunodiagnostic System
CKMB
Vitros® 7600 Integrated System
Vitros® 5600 Integrated System
Vitros® 4600 Chemistry System
Vitros® XT 3400 Chemistry System
Direct HDL
Vitros® 7600 Integrated System
Vitros® 5600 Integrated System
Vitros® 4600 Chemistry System
Vitros® XT 3400 Chemistry System
Direct LDL
Vitros® 7600 Integrated System
Vitros® 5600 Integrated System
Vitros® 4600 Chemistry System
Homocysteine
Vitros® 7600 Integrated System
Vitros® 5600 Integrated System
Vitros® 4600 Chemistry System
hsTroponin (D)
Vitros® 7600 Integrated System
Vitros® 5600 Integrated System
Vitros® 3600 Immunodiagnostic System
Vitros® ECI/ECiQ Immunodiagnostic System
LDHi
Vitros® 7600 Integrated System
Vitros® 5600 Integrated System
Vitros® 4600 Chemistry System
Vitros® XT 3400 Chemistry System
Lipoprotein(a)*
Vitros® 7600 Integrated System
Vitros® 5600 Integrated System
Vitros® 4600 Chemistry System
Myoglobin
Vitros® 7600 Integrated System
Vitros® 5600 Integrated System
Vitros® 3600 Immunodiagnostic System
Vitros® ECI/ECiQ Immunodiagnostic System
NT-proBNP
Vitros® 7600 Integrated System
Vitros® 5600 Integrated System
Vitros® 3600 Immunodiagnostic System
Vitros® ECI/ECiQ Immunodiagnostic System
Triglycerides
Vitros® 7600 Integrated System
Vitros® 5600 Integrated System
Vitros® 4600 Chemistry System
Vitros® XT 3400 Chemistry System
Troponin I ES
Vitros® 7600 Integrated System
Vitros® 5600 Integrated System
Vitros® 3600 Immunodiagnostic System
Vitros® ECI/ECiQ Immunodiagnostic System
The Vitros® System
-
Vitros® 7600 Integrated System
-
Vitros® 5600 Integrated System
-
Vitros® 3600 Immunodiagnostic System
-
Vitros® ECI/ECiQ Immunodiagnostic System
-
Vitros® 4600 Chemistry System
-
Vitros® XT 3400 Chemistry System
D = In development/currently not available.
* MicroTip Partnership Assay (MPA); Reagents and validated applications available directly from QuidelOrtho.
Assay menu disclaimer:
This document contains information which is targeted to a wide range of audiences and could contain product details or information otherwise not valid or applicable to your country. Please remember to consult your local legal restrictions, regulations, registrations or intended uses in the country of your origin. Product availability may vary from country to country and is subject to varying regulatory requirements. New QuidelOrtho branding may not be available in all markets, subject to country specific regulatory approval. Please confirm with your local commercial team. Some assays not for use in the United States.
Related products
